Nath Bio-Genes Share Price
Nath Bio-Genes Share Price Today
As of 14 Aug 2026, Nath Bio-Genes share price is ₹155.05. The stock opened at ₹156.00, compared to its previous close of ₹155.08. During today's trading session, Nath Bio-Genes share price moved in the range of ₹154.00 to ₹156.00, with an average price of ₹155.00 for the day. Looking at its last 52-week, the stock has touched a low of ₹126.15 and a high of ₹204.00. On the performance front, Nath Bio-Genes share price has increased by 4.64% over the last six months and is down 11.34% on a year-on-year basis.
Nath Bio-Genes Returns Calculator
About Nath Bio-Genes
Nath Bio-Genes (India) Limited is an India-based company, which is engaged in the business of production, processing, and marketing of hybrid and GM Seeds. The Company has a product range of field crops, vegetable crops and plant nutrient supplements. The major processing plants are situated at Aurangabad (MS), and Munipalli, Nizamabad (TG). The Company’s product categories include oilseeds and fiber, field crops, vegetables, and plant nutrition. Its fiber and oil seeds include cotton and mustard. The Company's vegetable crop range includes chili, okra, tomato, bottle gourd, bitter gourd, cucumber, coriander, pumpkin, and others. Its field crops include corn, jowar, hybrid paddy, research paddy and wheat. Its plant nutrition products include WINPro GOLii, WINall and Win Chin Win. The Company’s forage products include NUTRIMAX and NUTRIMAX GOLD. It has seed processing facilities and processing plants located in Maharashtra, Telangana, and Andhra Pradesh.
Nath Bio-Genes Financial Highlights
- Revenue: Nath Bio-Genes reported revenue of ₹452.91 crore in FY26 vs ₹369.46 crore in FY25. It showed an increase of 22.59% on a yearly basis.
- Operating Profit: Nath Bio-Genes reported an operating profit of ₹46.30 crore in FY26 vs ₹40.04 crore in FY25. It showed an increase of 15.63% on a year-on-year basis.
- Net Profit: Nath Bio-Genes reported a net profit of ₹41.63 crore in FY26 vs ₹38.60 crore in FY25. It showed an increase of 7.85% on a yearly basis.
Nath Bio-Genes Quarterly Result Highlights
- Nath Bio-Genes reported revenue of ₹330.30 crore in Jun 2026, compared with ₹53.97 crore in Mar 2026, representing an increase of 512.01% on a quarter-on-quarter (QoQ) basis.
- Nath Bio-Genes reported an operating profit of ₹32.98 crore in Jun 2026, compared with ₹2.49 crore in Mar 2026, representing an increase of 1,224.50% on a quarter-on-quarter (QoQ) basis.
- Nath Bio-Genes reported a profit of ₹32.26 crore in Jun 2026, compared with ₹0.01 crore in Mar 2026, reflecting an increase of 3,22,700.00% on a QoQ basis.
- The earnings per share (EPS) of Nath Bio-Genes stood at ₹20.14 during Jun 2026.
| Sep 2025 | 0.32% |
|---|---|
| Dec 2025 | 0.31% |
| Mar 2026 | 0.23% |
| Jun 2026 | 0.27% |
Nath Bio-Genes Shareholder Returns
Nath Bio-Genes Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Hindustan Unilever | 4,91,816.00 | 32.85 | 10.09 | 22.41% | 0.03 | 26.21% | 209.50 | 1.99% | 0.81 | 65.66 |
| Nestle India | 2,88,669.00 | 75.76 | 55.98 | 67.85% | 0.08 | 84.03% | 27.53 | 0.80% | 1.82 | 18.38 |
| Varun Beverages | 1,48,304.00 | 52.65 | 8.59 | 15.51% | 0.02 | 19.85% | 53.42 | 0.21% | 0.68 | 7.91 |
| Britannia Industries | 1,35,512.00 | 51.91 | 26.54 | 49.61% | 0.29 | 51.85% | 192.69 | 1.61% | 2.08 | 106.35 |
| Marico | 1,11,772.00 | 57.28 | 26.55 | 41.85% | 0.03 | 40.56% | 44.73 | 0.47% | 1.31 | 15.17 |
| Tata Consumer Products | 1,07,926.00 | 65.73 | 4.95 | 7.08% | 0.04 | 8.90% | 179.90 | 0.94% | 0.67 | 16.52 |
| LENSKART SOLUTIONS LTD | 1,03,767.00 | 155.36 | 11.87 | 5.65% | 0.20 | 7.00% | 52.43 | 0.00% | 0.47 | 2.80 |
| Godrej Consumer Products | 95,372.00 | 49.84 | 7.54 | 14.71% | 0.38 | 17.09% | 76.66 | 2.15% | 0.72 | 14.81 |
| Dabur India | 72,732.00 | 37.37 | 6.37 | 16.59% | 0.08 | 20.18% | 42.43 | 1.99% | 0.82 | 8.41 |
| Colgate Palmolive | 9,183.40 | 23.68 | 27.81 | 158.62% | 0.03 | 179.72% | 58.24 | 2.90% | 1.81 | 48.73 |
Nath Bio-Genes Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹364.91 | ₹332.62 | ₹301.36 | ₹278.36 |
| Other Income | ₹4.55 | ₹0.63 | ₹0.55 | ₹1.85 |
| Total Revenue | ₹369.45 | ₹333.25 | ₹301.92 | ₹280.22 |
| Total Expenses | ₹329.41 | ₹295.14 | ₹265.75 | ₹254.87 |
| Profit Before Tax | ₹40.58 | ₹41.56 | ₹36.16 | -₹63.43 |
| Tax | ₹1.98 | ₹1.95 | ₹1.15 | ₹3.95 |
| Profit After Tax | ₹38.60 | ₹39.62 | ₹35.01 | -₹67.39 |
| EPS - Basic | ₹20.14 | ₹21.34 | ₹18.43 | -₹35.55 |
| EPS - Diluted | ₹20.14 | ₹21.34 | ₹18.43 | -₹35.55 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹40.58 | ₹41.56 | ₹36.16 | -₹63.43 |
| Income before WC changes | ₹53.62 | ₹51.84 | ₹49.10 | ₹38.85 |
| Change in Assets | -₹134.36 | -₹21.29 | -₹20.56 | -₹51.47 |
| Change in Liabilities | ₹99.40 | ₹44.38 | ₹10.75 | ₹32.55 |
| Change in WC | -₹34.95 | ₹23.09 | -₹9.81 | -₹18.93 |
| Cash flow from Operations | ₹17.58 | ₹74.59 | ₹38.37 | ₹17.05 |
| Cash flow from Investing | -₹3.96 | -₹27.40 | -₹2.88 | -₹19.85 |
| Cash flow from Financing | -₹2.13 | -₹7.78 | -₹1.67 | -₹22.23 |
| Total Cash Flow | ₹11.49 | ₹39.41 | ₹33.81 | -₹25.04 |
| Cash (Start of the year) | ₹77.41 | ₹38.00 | ₹4.18 | ₹29.22 |
| Cash (End of the year) | ₹88.90 | ₹77.41 | ₹38.00 | ₹4.18 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹336.20 | ₹308.57 | ₹271.97 | ₹271.72 |
| Current Assets | ₹690.01 | ₹571.66 | ₹520.83 | ₹467.77 |
| Total Assets | ₹1,026.21 | ₹880.23 | ₹792.80 | ₹739.49 |
| Current Liabilities | ₹365.30 | ₹262.45 | ₹216.45 | ₹194.29 |
| Net Current Asset | ₹324.71 | ₹309.22 | ₹304.38 | ₹273.47 |
| Non-Current Liabilities | ₹16.52 | ₹7.87 | ₹3.19 | ₹3.28 |
| Equity Capital | ₹644.39 | ₹609.92 | ₹573.15 | ₹541.92 |
| Total Equity & Liabilities | ₹1,026.21 | ₹880.23 | ₹792.80 | ₹739.49 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹362.31 | ₹332.62 | ₹301.29 | ₹278.36 |
| Other Income | ₹4.73 | ₹0.65 | ₹0.56 | ₹1.85 |
| Total Revenue | ₹367.04 | ₹333.28 | ₹301.85 | ₹280.22 |
| Total Expenses | ₹323.45 | ₹294.60 | ₹265.53 | ₹254.82 |
| Profit Before Tax | ₹44.12 | ₹42.12 | ₹36.32 | -₹63.39 |
| Tax | ₹1.98 | ₹1.95 | ₹1.15 | ₹3.95 |
| Profit After Tax | ₹42.14 | ₹40.18 | ₹35.17 | -₹67.34 |
| EPS - Basic | ₹22.00 | ₹21.63 | ₹18.51 | -₹35.52 |
| EPS - Diluted | ₹22.00 | ₹21.63 | ₹18.51 | -₹35.52 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹44.12 | ₹42.12 | ₹36.32 | -₹63.39 |
| Income before WC changes | ₹56.30 | ₹52.39 | ₹49.25 | ₹38.90 |
| Change in Assets | -₹127.41 | -₹19.86 | -₹20.69 | -₹51.52 |
| Change in Liabilities | ₹99.00 | ₹42.54 | ₹10.72 | ₹32.55 |
| Change in WC | -₹28.41 | ₹22.67 | -₹9.97 | -₹18.97 |
| Cash flow from Operations | ₹26.80 | ₹74.72 | ₹38.37 | ₹17.05 |
| Cash flow from Investing | -₹4.05 | -₹27.40 | -₹2.88 | -₹19.87 |
| Cash flow from Financing | -₹10.62 | -₹9.81 | -₹1.67 | -₹22.23 |
| Total Cash Flow | ₹12.13 | ₹37.52 | ₹33.82 | -₹25.05 |
| Cash (Start of the year) | ₹75.50 | ₹37.98 | ₹4.17 | ₹29.22 |
| Cash (End of the year) | ₹87.63 | ₹75.50 | ₹37.98 | ₹4.17 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹336.32 | ₹308.57 | ₹271.98 | ₹271.74 |
| Current Assets | ₹680.55 | ₹568.52 | ₹520.99 | ₹467.80 |
| Total Assets | ₹1,016.87 | ₹877.08 | ₹792.97 | ₹739.54 |
| Current Liabilities | ₹363.05 | ₹260.60 | ₹216.43 | ₹194.29 |
| Net Current Asset | ₹317.50 | ₹307.92 | ₹304.56 | ₹273.51 |
| Non-Current Liabilities | ₹5.15 | ₹5.83 | ₹3.19 | ₹3.28 |
| Equity Capital | ₹648.67 | ₹610.66 | ₹573.35 | ₹541.97 |
| Total Equity & Liabilities | ₹1,016.87 | ₹877.08 | ₹792.97 | ₹739.54 |
| 14 Aug | 0L |
|---|---|
| 13 Aug | 0L |
| 12 Aug | 0L |
| 11 Aug | 0L |
| 10 Aug | 0L |
| 7 Aug | 0L |
| Average | 0L |
Popular Stocks
Nath Bio-Genes Share Price FAQs
What is Nath Bio-Genes share price today?
Nath Bio-Genes share price is ₹155.05 as on 14 Aug, 2026, 13:37 IST.
How has the Nath Bio-Genes share price performed in the past?
In the last 1 year, Nath Bio-Genes delivered a return of -11.34%. The Nath Bio-Genes share price hit a high of ₹204.00 and low of ₹126.15.
How much is the Mutual Fund shareholding in Nath Bio-Genes shares?
The Mutual Fund Shareholding in Nath Bio-Genes was 0.01% at the end of Jun 2026.
What is the the 52-week high and low of Nath Bio-Genes shares ?
The 52-week high and low of Nath Bio-Genes share is ₹204.00 and ₹126.15 as of 14 Aug, 2026.
What is the market cap of Nath Bio-Genes?
The market capitalisation of Nath Bio-Genes is ₹293.61 Crores as on 14 Aug, 2026.
What are the stock symbols of Nath Bio-Genes?
The stock symbol of Nath Bio-Genes is NATHBIOGEN on the NSE, 537291 on the BSE, and the ISIN is INE448G01010.
What was yesterday's closing price of Nath Bio-Genes shares ?
Nath Bio-Genes shares closed yesterday at ₹155.08 on NSE & ₹154.50 on BSE
How to buy Nath Bio-Genes shares?
To buy Nath Bio-Genes shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy Nath Bio-Genes shares on Holidays?
No, shares of Nath Bio-Genes or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Nath Bio-Genes shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of Nath Bio-Genes?
The PE and PB ratio of Nath Bio-Genes is 7.59 and 0.43 respectively, as on 14 Aug, 2026, 13:37 IST.